Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-11-08
2005-11-08
Stockton, Laura L. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S394000, C546S273400, C548S304700
Reexamination Certificate
active
06962932
ABSTRACT:
New benzimidazole derivatives are described, their production and their use for the production of pharmaceutical agents for treatment and prevention of diseases that are associated with a microglia activation and T-cell-mediated immunological diseases, as well as pharmaceutical preparations that contain the new benzimidazole derivatives.
REFERENCES:
patent: 2002/0006948 (2002-01-01), Halfbrodt et al.
patent: WO 01/51473 (2001-07-01), None
Golub et al., Science, vol. 286, Oct. 15, 1999, pp. 531-537.
Blume Thorsten
Elger Bernd
Halfbrodt Wolfgang
Kuhnke Joachim
Moenning Ursula
Berlex Inc.
Schering Aktiengesellschaft
Stockton Laura L.
LandOfFree
1-phenyl-2-heteroaryl-substituted benzimdazole derivatives,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-phenyl-2-heteroaryl-substituted benzimdazole derivatives,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-phenyl-2-heteroaryl-substituted benzimdazole derivatives,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3520123